Type
Blood Testing
Biomarkers
4
Duration
15 min
Results
7 days
Sample
Blood (venous draw — fasting serum tube)
What's included
4 deliverables in this treatment
- Total cholesterol, HDL-cholesterol (protective), LDL-cholesterol (atherogenic), triglycerides
- ČSN EN ISO 15189-accredited laboratory analysis
- Results delivered within one week
- Individual test pricing allows extension to Apolipoprotein B, Lp(a) as needed
A fasting cholesterol and lipid panel at MEDILA measuring the four core cardiovascular risk markers: total cholesterol, HDL-cholesterol (protective), LDL-cholesterol (primary atherogenic marker), and triglycerides. This panel is the standard lipid screen used to assess cardiovascular risk in adults and to guide decisions about lifestyle changes and lipid-lowering therapy. LDL elevation is the primary target for cardiovascular risk reduction — European guidelines recommend LDL below 1.8 mmol/L for very high risk patients and below 2.6 mmol/L for high risk. HDL below 1.0 mmol/L in men and 1.2 mmol/L in women indicates reduced protective function. Triglycerides above 1.7 mmol/L signal metabolic syndrome risk. MEDILA's ISO 15189-accredited laboratories process fasting lipid panels with results returned within one week.
About this treatment
The lipid profile at MEDILA provides the fundamental cardiovascular risk assessment through four complementary cholesterol and triglyceride measurements — the core data set used by cardiologists, general practitioners, and preventive medicine specialists across Europe to stratify individual cardiovascular risk and guide treatment.
Total cholesterol alone is an inadequate risk indicator — a person with the same total cholesterol value can have very different cardiovascular risk depending on the proportion carried in different particle types. The four-marker panel addresses this by measuring each major lipoprotein class separately:
LDL-cholesterol (low-density lipoprotein) is the primary atherogenic lipoprotein. LDL particles carry cholesterol from the liver to peripheral tissues; when circulating in excess, they penetrate the arterial endothelium, are oxidised, and trigger the inflammatory cascade that leads to atherosclerotic plaque formation. LDL is the primary target of cardiovascular risk reduction: statins primarily lower LDL, and the evidence base for LDL reduction preventing…
Good to know
- Core markers
- Total cholesterol, HDL, LDL, triglycerides
- Fasting required
- 8–12 hours
- Accreditation
- ČSN EN ISO 15189 (ČIA)
- Results
- Within 1 week
Who is this for?
Cardiovascular risk assessment, LDL monitoring on statin therapy, metabolic syndrome screening, pre-employment health screening, annual wellness baseline
Preparation required
Fast 8–12 hours before the draw (water only). Avoid alcohol for 24 hours before collection. Blood draw fee charged additionally.
Panel categories
Biomarkers tested
4Often called 'good' cholesterol, HDL carries cholesterol away from arteries back to the liver for removal. Higher HDL levels are protective against heart disease. Exercise, healthy fats, and moderate alcohol intake can raise HDL.
Often called 'bad' cholesterol, LDL deposits cholesterol in artery walls, contributing to plaque buildup and atherosclerosis. LDL is the primary target for cardiovascular risk reduction through diet, exercise, and medication.
The combined measure of all cholesterol in your blood, including HDL, LDL, and VLDL. While useful as an overview, the breakdown between HDL and LDL is more clinically meaningful for assessing cardiovascular risk.
The most common type of fat in the body, stored for energy. Elevated triglycerides — often from excess sugar, alcohol, or calories — increase cardiovascular risk and can cause pancreatitis at very high levels.
About the clinic
Reviews, team and credentials
Independent review links and clinic-reported team information.
Clinical team
MEDILA's clinical team spans over 300 staff across eight specialist laboratories, including clinical biochemists, haematologists, immunologists, microbiologists, molecular biologists, geneticists, histologists, and allergologists. The self-pay Moje MEDILA service includes a written physician commentary on all results prepared by the laboratory's medical staff, and the larger comprehensive screening packages include…
Languages: Czech
Treatment highlights
- Total cholesterol, HDL-cholesterol (protective), LDL-cholesterol (atherogenic), triglycerides
- ČSN EN ISO 15189-accredited laboratory analysis
+2 more items in What's included
Institutional pricing from 24 Kč per individual cholesterol marker (total cholesterol 24 Kč; HDL 51 Kč; LDL 62 Kč; triglycerides 38 Kč) — core four-marker panel approximately 175–212 Kč combined. Self-pay patients order via mojemedila.cz. Blood draw fee (42 Kč adults) charged additionally.